Equity Overview
Price & Market Data
Price: $46.05
Daily Change: +$1.50 / 3.27%
Daily Range: $43.10 - $46.50
Market Cap: $2,021,189,760
Daily Volume: 119,933
Performance Metrics
1 Week: 3.32%
1 Month: -11.12%
3 Months: 605.2%
6 Months: 770.2%
1 Year: 770.2%
YTD: 698.1%
Company Details
Employees: 27
Sector: Health technology
Industry: Medical specialties
Country:
Details
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Selected stocks
Brighthouse Financial, Inc. - Depositary Shares 6.6% Non-Cumulative Preferred Stock, Series A (BHFAP)
Brighthouse Financial, Inc. - Depositary Shares, each representing a 1/1,000th interest in a share of 6.750% Non-Cumulative Preferred Stock, Series B (BHFAO)
Brighthouse Financial, Inc. - depositary shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series C (BHFAN)